Literature DB >> 32206531

Intentional Subtotal Resection of Vestibular Schwannoma: A Reexamination.

Ben A Strickland1, Kristine Ravina1, Robert C Rennert2, Anna Jackanich1, Ksenia Aaron3, Joshua Bakhsheshian1, Jonathan J Russin1, Rick A Friedman4, Steven L Giannotta1.   

Abstract

Background  Treatment of vestibular schwannomas (VS) remains controversial. Historical surgical series prioritized gross total resections (GTR); however, near total resections (NTR) and intentional subtotal resections (STR) aiming at improving cranial nerve outcomes are becoming more popular. Objective  The main purpose of this article is to assess the tumor control and facial nerve outcomes in VS patients treated with STR or NTR. Methods  VS patients undergoing STR or NTR at our institution between 1984 and 2016 were retrospectively reviewed. Patient demographics, extent of tumor resection, facial nerve injury, tumor recurrence, and need for Gamma Knife radiosurgery were analyzed. Facial nerve outcomes were quantified using House-Brackmann (HB) scores. Tumor regrowth was defined by the San Francisco criteria. Results  Four-hundred fifty-seven VS resections were performed in a 32-year period. Sixty cases met inclusion criteria. The mean (range) follow-up duration was 30.9 (12-103) months. The STR cohort ( n  = 33) demonstrated regrowth in 12 patients (36.3%) at an average of 23.6 months. The NTR cohort ( n  = 27) did not experience tumor recurrence. Risk of tumor recurrence was positively correlated with preoperative tumor size ( p  = 0.002), size of residual tumor ( p  < 0.001), and STR ( p  < 0.001). Facial nerve outcomes of HB1-2 were observed in the majority of patients in both cohorts (74.1% NTR, 56% STR), though NTR was associated with a higher likelihood of facial nerve recovery ( p  = 0.003). Conclusion  GTR remains the gold standard as long as facial nerve outcomes remain acceptable. NTR achieved superior tumor control and higher likelihood of facial nerve recovery compared with STR. © Thieme Medical Publishers.

Entities:  

Keywords:  near total resection; skull base surgery; subtotal resection; vestibular schwannoma

Year:  2019        PMID: 32206531      PMCID: PMC7082167          DOI: 10.1055/s-0039-1679898

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  21 in total

1.  Analysis of patterns of care of brain tumor patients in the United States: a study of the Brain Tumor Section of the AANS and the CNS and the Commission on Cancer of the ACS.

Authors:  M S Mahaley; C Mettlin; N Natarajan; E R Laws; B B Peace
Journal:  Clin Neurosurg       Date:  1990

2.  The behaviour of residual tumour after the intentional incomplete excision of a vestibular schwannoma: is it such a bad thing to leave some behind?

Authors:  M I Syed; A Wolf; O Ilan; C O Hughes; J Chung; M Tymianski; D D Pothier; J A Rutka
Journal:  Clin Otolaryngol       Date:  2016-05-26       Impact factor: 2.597

3.  Volumetric measurement of vestibular schwannoma tumour growth following partial resection: predictors for recurrence.

Authors:  Siavosh Vakilian; Luis Souhami; Denis Melançon; Anthony Zeitouni
Journal:  J Neurol Surg B Skull Base       Date:  2012-04

4.  Report of 190 consecutive cases of large acoustic tumors (vestibular schwannoma) removed via the translabyrinthine approach.

Authors:  T H Lanman; D E Brackmann; W E Hitselberger; B Subin
Journal:  J Neurosurg       Date:  1999-04       Impact factor: 5.115

5.  Functional outcome after complete surgical removal of giant vestibular schwannomas.

Authors:  Madjid Samii; Venelin M Gerganov; Amir Samii
Journal:  J Neurosurg       Date:  2010-04       Impact factor: 5.115

6.  Resection of large vestibular schwannomas: facial nerve preservation in the context of surgical approach and patient-assessed outcome.

Authors:  Douglas E Anderson; John Leonetti; Joshua J Wind; Denise Cribari; Karen Fahey
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

7.  Management of Residual Tumor After Limited Subtotal Resection of Large Vestibular Schwannomas: Lessons Learned and Rationale for Specialized Care.

Authors:  William R Copeland; Matthew L Carlson; Brian A Neff; Colin L W Driscoll; Michael J Link
Journal:  World Neurosurg       Date:  2017-06-21       Impact factor: 2.104

8.  Quality of Life in Patients with Vestibular Schwannomas Following Gross Total or Less than Gross Total Microsurgical Resection: Should We be Taking the Entire Tumor Out?

Authors:  Michael J Link; Morten Lund-Johansen; Christine M Lohse; Colin L W Driscoll; Ehrling Myrseth; Oystein Vesterli Tveiten; Matthew L Carlson
Journal:  Neurosurgery       Date:  2018-04-01       Impact factor: 4.654

9.  The fate of the tumor remnant after less-than-complete acoustic neuroma resection.

Authors:  Dov C Bloch; John S Oghalai; Robert K Jackler; Monica Osofsky; Lawrence H Pitts
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497

10.  Outcomes in Patients with Vestibular Schwannoma after Subtotal Resection and Adjuvant Radiosurgery.

Authors:  Hesham Radwan; Mark Bruce Eisenberg; Jonathan Petrus Sandberg Knisely; Maged Mofied Ghaly; Michael Schulder
Journal:  Stereotact Funct Neurosurg       Date:  2016-08-12       Impact factor: 1.875

View more
  4 in total

1.  The natural history of vestibular schwannoma growth-prospective 40-year data from an unselected national cohort.

Authors:  Martin Reznitsky; Mette Marie Babiel Schmidt Petersen; Niels West; Sven-Eric Stangerup; Per Cayé-Thomasen
Journal:  Neuro Oncol       Date:  2021-05-05       Impact factor: 12.300

2.  Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis.

Authors:  Umberto Tosi; Omri Maayan; Anjile An; Miguel E Tusa Lavieri; Sergio W Guadix; Antonio P DeRosa; Paul J Christos; Susan Pannullo; Philip E Stieg; Andrew Brandmaier; Jonathan P S Knisely; Rohan Ramakrishna
Journal:  J Neurooncol       Date:  2022-01-18       Impact factor: 4.130

3.  Applicability of contemporary quality indicators in vestibular surgery-do they accurately measure tumor inherent postoperative complications of vestibular schwannomas?

Authors:  Stephanie Schipmann; Sebastian Lohmann; Bilal Al Barim; Eric Suero Molina; Michael Schwake; Özer Altan Toksöz; Walter Stummer
Journal:  Acta Neurochir (Wien)       Date:  2021-12-02       Impact factor: 2.216

4.  Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology.

Authors:  Moran Amit; Tongxin Xie; Frederico O Gleber-Netto; Patrick J Hunt; Gautam U Mehta; Diana Bell; Deborah A Silverman; Ismail Yaman; Yi Ye; Jared K Burks; Gregory N Fuller; Paul W Gidley; Marc-Elie Nader; Shaan M Raza; Franco DeMonte
Journal:  J Exp Clin Cancer Res       Date:  2022-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.